Company Filing History:
Years Active: 2012-2015
Title: The Innovative Contributions of Deborah Ockert
Introduction
Deborah Ockert is a notable inventor based in Hamburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical treatments. With a total of 3 patents to her name, her work has garnered attention in the scientific community.
Latest Patents
One of her latest patents involves pyrazolone derivatives as PDE4 inhibitors. The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is recognized as a novel effective inhibitor of type 4 phosphodiesterase. This compound shows promise in the treatment of psoriasis and atopic dermatitis, highlighting her innovative approach to addressing complex medical conditions.
Career Highlights
Throughout her career, Deborah has worked with prominent companies in the pharmaceutical industry, including Takeda GmbH and Nycomed GmbH. Her experience in these organizations has allowed her to develop and refine her expertise in drug development and innovation.
Collaborations
Deborah has collaborated with several professionals in her field, including Beate Schmidt and Christian Scheufler. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Deborah Ockert's contributions to the field of pharmaceuticals through her innovative patents and collaborations demonstrate her commitment to improving medical treatments. Her work continues to inspire future advancements in the industry.